nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—ABCB1—peripheral nervous system neoplasm	0.515	1	CbGaD
Chlorpropamide—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0558	0.153	CbGbCtD
Chlorpropamide—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0557	0.153	CbGbCtD
Chlorpropamide—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0557	0.153	CbGbCtD
Chlorpropamide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0534	0.146	CbGbCtD
Chlorpropamide—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0386	0.106	CbGbCtD
Chlorpropamide—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0238	0.0652	CbGbCtD
Chlorpropamide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0228	0.0627	CbGbCtD
Chlorpropamide—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0222	0.0608	CbGbCtD
Chlorpropamide—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0218	0.0598	CbGbCtD
Chlorpropamide—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0149	0.0408	CbGbCtD
Chlorpropamide—Digestion impaired—Melphalan—peripheral nervous system neoplasm	0.00306	0.0254	CcSEcCtD
Chlorpropamide—Eruption—Dactinomycin—peripheral nervous system neoplasm	0.00275	0.0228	CcSEcCtD
Chlorpropamide—Inappropriate antidiuretic hormone secretion—Vincristine—peripheral nervous system neoplasm	0.0026	0.0216	CcSEcCtD
Chlorpropamide—Inappropriate antidiuretic hormone secretion—Cisplatin—peripheral nervous system neoplasm	0.0023	0.0191	CcSEcCtD
Chlorpropamide—Drug interaction—Tretinoin—peripheral nervous system neoplasm	0.00223	0.0185	CcSEcCtD
Chlorpropamide—Drug interaction—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.0185	CcSEcCtD
Chlorpropamide—Drug interaction—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.014	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.00164	0.0136	CcSEcCtD
Chlorpropamide—Drug interaction—Vincristine—peripheral nervous system neoplasm	0.00163	0.0135	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Tretinoin—peripheral nervous system neoplasm	0.00159	0.0132	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.0132	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00159	0.0132	CcSEcCtD
Chlorpropamide—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.00149	0.0124	CcSEcCtD
Chlorpropamide—Fluid retention—Cisplatin—peripheral nervous system neoplasm	0.00127	0.0105	CcSEcCtD
Chlorpropamide—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.00124	0.0103	CcSEcCtD
Chlorpropamide—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.00122	0.0101	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.01	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00985	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00985	CcSEcCtD
Chlorpropamide—Eruption—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00927	CcSEcCtD
Chlorpropamide—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.0011	0.00915	CcSEcCtD
Chlorpropamide—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00898	CcSEcCtD
Chlorpropamide—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00898	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00893	CcSEcCtD
Chlorpropamide—Eruption—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00858	CcSEcCtD
Chlorpropamide—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00837	CcSEcCtD
Chlorpropamide—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.000983	0.00816	CcSEcCtD
Chlorpropamide—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.000983	0.00816	CcSEcCtD
Chlorpropamide—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.000974	0.00809	CcSEcCtD
Chlorpropamide—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.0009	0.00748	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.000898	0.00746	CcSEcCtD
Chlorpropamide—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.000883	0.00734	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.000865	0.00719	CcSEcCtD
Chlorpropamide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.0068	CcSEcCtD
Chlorpropamide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000816	0.00678	CcSEcCtD
Chlorpropamide—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000803	0.00667	CcSEcCtD
Chlorpropamide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000799	0.00664	CcSEcCtD
Chlorpropamide—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.000796	0.00661	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.000781	0.00649	CcSEcCtD
Chlorpropamide—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.00619	CcSEcCtD
Chlorpropamide—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.000729	0.00606	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000729	0.00605	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000723	0.00601	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000723	0.00601	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.006	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000713	0.00593	CcSEcCtD
Chlorpropamide—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000709	0.00589	CcSEcCtD
Chlorpropamide—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000704	0.00585	CcSEcCtD
Chlorpropamide—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000704	0.00585	CcSEcCtD
Chlorpropamide—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000695	0.00577	CcSEcCtD
Chlorpropamide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000662	0.0055	CcSEcCtD
Chlorpropamide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000655	0.00544	CcSEcCtD
Chlorpropamide—Fluid retention—Epirubicin—peripheral nervous system neoplasm	0.000651	0.00541	CcSEcCtD
Chlorpropamide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00065	0.0054	CcSEcCtD
Chlorpropamide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00065	0.0054	CcSEcCtD
Chlorpropamide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000647	0.00538	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000644	0.00535	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000643	0.00534	CcSEcCtD
Chlorpropamide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000642	0.00533	CcSEcCtD
Chlorpropamide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000642	0.00533	CcSEcCtD
Chlorpropamide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000641	0.00533	CcSEcCtD
Chlorpropamide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000639	0.00531	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000637	0.0053	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000637	0.0053	CcSEcCtD
Chlorpropamide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000633	0.00526	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000629	0.00523	CcSEcCtD
Chlorpropamide—Fluid retention—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.00501	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.00495	CcSEcCtD
Chlorpropamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000591	0.00491	CcSEcCtD
Chlorpropamide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000591	0.00491	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000591	0.00491	CcSEcCtD
Chlorpropamide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000587	0.00487	CcSEcCtD
Chlorpropamide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000587	0.00487	CcSEcCtD
Chlorpropamide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000581	0.00483	CcSEcCtD
Chlorpropamide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000579	0.00481	CcSEcCtD
Chlorpropamide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000575	0.00478	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.00455	CcSEcCtD
Chlorpropamide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000533	0.00443	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000528	0.00439	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000528	0.00439	CcSEcCtD
Chlorpropamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000527	0.00437	CcSEcCtD
Chlorpropamide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000525	0.00436	CcSEcCtD
Chlorpropamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000523	0.00434	CcSEcCtD
Chlorpropamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000522	0.00434	CcSEcCtD
Chlorpropamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000522	0.00434	CcSEcCtD
Chlorpropamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000516	0.00428	CcSEcCtD
Chlorpropamide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000514	0.00427	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00051	0.00424	CcSEcCtD
Chlorpropamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000509	0.00423	CcSEcCtD
Chlorpropamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000505	0.0042	CcSEcCtD
Chlorpropamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000505	0.0042	CcSEcCtD
Chlorpropamide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.0005	0.00416	CcSEcCtD
Chlorpropamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000499	0.00414	CcSEcCtD
Chlorpropamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.00409	CcSEcCtD
Chlorpropamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000492	0.00409	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.00406	CcSEcCtD
Chlorpropamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000488	0.00406	CcSEcCtD
Chlorpropamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000488	0.00406	CcSEcCtD
Chlorpropamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.00404	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.00401	CcSEcCtD
Chlorpropamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000479	0.00398	CcSEcCtD
Chlorpropamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000473	0.00393	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.00392	CcSEcCtD
Chlorpropamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000469	0.0039	CcSEcCtD
Chlorpropamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000469	0.0039	CcSEcCtD
Chlorpropamide—Rash—Topotecan—peripheral nervous system neoplasm	0.000469	0.0039	CcSEcCtD
Chlorpropamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000469	0.00389	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000467	0.00388	CcSEcCtD
Chlorpropamide—Headache—Topotecan—peripheral nervous system neoplasm	0.000466	0.00387	CcSEcCtD
Chlorpropamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000466	0.00387	CcSEcCtD
Chlorpropamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000466	0.00387	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000465	0.00387	CcSEcCtD
Chlorpropamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000463	0.00385	CcSEcCtD
Chlorpropamide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.00384	CcSEcCtD
Chlorpropamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000463	0.00384	CcSEcCtD
Chlorpropamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000463	0.00384	CcSEcCtD
Chlorpropamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000459	0.00382	CcSEcCtD
Chlorpropamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000454	0.00378	CcSEcCtD
Chlorpropamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000444	0.00369	CcSEcCtD
Chlorpropamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000442	0.00367	CcSEcCtD
Chlorpropamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000439	0.00364	CcSEcCtD
Chlorpropamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000439	0.00364	CcSEcCtD
Chlorpropamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000433	0.0036	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000428	0.00355	CcSEcCtD
Chlorpropamide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00354	CcSEcCtD
Chlorpropamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000416	0.00346	CcSEcCtD
Chlorpropamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000414	0.00344	CcSEcCtD
Chlorpropamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000413	0.00343	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000412	0.00342	CcSEcCtD
Chlorpropamide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000409	0.0034	CcSEcCtD
Chlorpropamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00329	CcSEcCtD
Chlorpropamide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.00328	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00326	CcSEcCtD
Chlorpropamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000384	0.00319	CcSEcCtD
Chlorpropamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000383	0.00318	CcSEcCtD
Chlorpropamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00038	0.00316	CcSEcCtD
Chlorpropamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00038	0.00315	CcSEcCtD
Chlorpropamide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.00314	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000377	0.00313	CcSEcCtD
Chlorpropamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00307	CcSEcCtD
Chlorpropamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000369	0.00306	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00302	CcSEcCtD
Chlorpropamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00298	CcSEcCtD
Chlorpropamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00298	CcSEcCtD
Chlorpropamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000357	0.00296	CcSEcCtD
Chlorpropamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000356	0.00296	CcSEcCtD
Chlorpropamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.00293	CcSEcCtD
Chlorpropamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00291	CcSEcCtD
Chlorpropamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000347	0.00288	CcSEcCtD
Chlorpropamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000343	0.00285	CcSEcCtD
Chlorpropamide—Rash—Vincristine—peripheral nervous system neoplasm	0.00034	0.00282	CcSEcCtD
Chlorpropamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000338	0.00281	CcSEcCtD
Chlorpropamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00276	CcSEcCtD
Chlorpropamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.00275	CcSEcCtD
Chlorpropamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000326	0.00271	CcSEcCtD
Chlorpropamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000326	0.00271	CcSEcCtD
Chlorpropamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00032	0.00266	CcSEcCtD
Chlorpropamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000309	0.00257	CcSEcCtD
Chlorpropamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000303	0.00252	CcSEcCtD
Chlorpropamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.0025	CcSEcCtD
Chlorpropamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000301	0.0025	CcSEcCtD
Chlorpropamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000299	0.00248	CcSEcCtD
Chlorpropamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000289	0.0024	CcSEcCtD
Chlorpropamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00235	CcSEcCtD
Chlorpropamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000278	0.00231	CcSEcCtD
Chlorpropamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000275	0.00229	CcSEcCtD
Chlorpropamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000274	0.00227	CcSEcCtD
Chlorpropamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00223	CcSEcCtD
Chlorpropamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000259	0.00216	CcSEcCtD
Chlorpropamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00206	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00199	CcSEcCtD
Chlorpropamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00194	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.00184	CcSEcCtD
Chlorpropamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00179	CcSEcCtD
Chlorpropamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00179	CcSEcCtD
Chlorpropamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000213	0.00177	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00176	CcSEcCtD
Chlorpropamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00166	CcSEcCtD
Chlorpropamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00164	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00162	CcSEcCtD
Chlorpropamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00162	CcSEcCtD
Chlorpropamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.0015	CcSEcCtD
Chlorpropamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00144	CcSEcCtD
Chlorpropamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00139	CcSEcCtD
Chlorpropamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00135	CcSEcCtD
Chlorpropamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00133	CcSEcCtD
Chlorpropamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00129	CcSEcCtD
Chlorpropamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00129	CcSEcCtD
Chlorpropamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00128	CcSEcCtD
Chlorpropamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00127	CcSEcCtD
Chlorpropamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00124	CcSEcCtD
Chlorpropamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00121	CcSEcCtD
Chlorpropamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.0012	CcSEcCtD
Chlorpropamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00119	CcSEcCtD
Chlorpropamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00118	CcSEcCtD
Chlorpropamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00112	CcSEcCtD
